ZINGIBERACEAE Zingiber officinale  Roscoe

 Synonym

    none ...
 Thai / English name

  • ขิง*

[3-4] of 4 article(s) found

 หน้า  1  2  

[3] CYTOCHROME P450 INHIBITORY POTENTIAL AND RP-HPLC STANDARDIZATION OF TRIKATU—A RASAYANA FROM INDIAN AYURVEDA.
RANJIT K. HARWANSH,KAKALI MUKHERJEE,SANTANU BHADRA,ET AL.
J ETHNOPHARMACOL 2014 Vol.153(),674-81  $51721 [Full]

Part Used : เหง้า
Activity : CYP2D6 INHIBITION
Solvent/Active Compound : Trikatu laboratory formulation / DMSO
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : 800-6.5 micrograms/mL
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : Result: IC50 value of extracts on metabolism mediated by CYP3A4 and CYP2D6 were 223.254+/-0.92 and 245.23+/-1.92 micrograms/mL, respectively.
Note : Type of experiment: rat liver microsomes. The amount of 6-gingerol present in extract of Zingiber officinal, Trikatumarketed formulation and Trikatu laboratory formulation was estimated to be about 6.21+/-1.03%, 5.3+/-1.21% and 4.95+/-2.34% (w/w), respectively. Piperine was found to be 7.31+/-2.36% (Piper longum), 8.41+/-2.54% (Piper nigrum), 7.89+/-2.12% (Trikatu marketed formulation) and 6.70+/-2.13% (w/w) (Trikatu laboratory formulation).

Part Used : ผล
Activity : CYP2D6 INHIBITION
Solvent/Active Compound : Trikatu laboratory formulation / DMSO
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : 800-6.5 micrograms/mL
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : Result: IC50 value of extracts on metabolism mediated by CYP3A4 and CYP2D6 were 223.254+/-0.92 and 245.23+/-1.92 micrograms/mL, respectively.
Note : Type of experiment: rat liver microsomes. The amount of 6-gingerol present in extract of Zingiber officinal, Trikatumarketed formulation and Trikatu laboratory formulation was estimated to be about 6.21+/-1.03%, 5.3+/-1.21% and 4.95+/-2.34% (w/w), respectively. Piperine was found to be 7.31+/-2.36% (Piper longum), 8.41+/-2.54% (Piper nigrum), 7.89+/-2.12% (Trikatu marketed formulation) and 6.70+/-2.13% (w/w) (Trikatu laboratory formulation).

[4] INHIBITORY ACTIVITIES OF THAI MEDICINAL PLANTS WITH PROMISING ACTIVITIES AGAINST MALARIA AND CHOLANGIOCARCINOMA ON HUMAN CYTOCHROME P450.
WIRIYAPORN SUMSAKUL,WIRATCHANEE MAHAVORASIRIKUL,KESARA NA-BANGCHANG
PHYTOTHER RES 2015 Vol.29(),1926-33  $60695 [Full]

Part Used : เหง้า
Activity : CYP2D6 INHIBITION
Solvent/Active Compound : ethanol
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : -
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : The selective inhibitor quinidine showed the most potent inhibitory activity on CYP2D6 activity with mean IC50 of 0.97 microgram/mL. DM, DL and PI showed the highest inhibitory activities (mean IC50 2.93-9.57 microgram/mL). The potency of inhibitory activity of DM was comparable to that of quinidine (p > 0.05). PC, GM and ZO exhibited moderate potencies (mean IC50 23.40-31.32 microgram/mL), and MF and AL exhibited relatively low potencies (mean IC50 195.83 and 313.51 microgram/mL, respectively). (substrate: extromethorphan)
Note : Piper chaba (PC), Dioscroea membranacea (DI), Dracaenal oureiri (DG), Atractylodes lancea (AL), Plumbago indica (PI), Zingiber officinale (ZO), Myristica fragrans (MF), Garcinia mangostana (GM).


 หน้า  1  2